212 related articles for article (PubMed ID: 29654903)
1. Host cell protein removal from biopharmaceutical preparations: Towards the implementation of quality by design.
Goey CH; Alhuthali S; Kontoravdi C
Biotechnol Adv; 2018; 36(4):1223-1237. PubMed ID: 29654903
[TBL] [Abstract][Full Text] [Related]
2. Polymer-mediated flocculation of transient CHO cultures as a simple, high throughput method to facilitate antibody discovery.
Schmitt MG; Rajendra Y; Hougland MD; Boyles JS; Barnard GC
Biotechnol Prog; 2017 Sep; 33(5):1393-1400. PubMed ID: 28722325
[TBL] [Abstract][Full Text] [Related]
3. Mild hypothermic culture conditions affect residual host cell protein composition post-Protein A chromatography.
Goey CH; Bell D; Kontoravdi C
MAbs; 2018 Apr; 10(3):476-487. PubMed ID: 29381421
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process.
Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC
J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041
[TBL] [Abstract][Full Text] [Related]
5. Online integrity monitoring in the protein A step of mAb production processes-increasing reliability and process robustness.
Bork C; Holdridge S; Walter M; Fallon E; Pohlscheidt M
Biotechnol Prog; 2014; 30(2):383-90. PubMed ID: 24376144
[TBL] [Abstract][Full Text] [Related]
6. Effect of Host Cell Protein on Chinese Hamster Ovary Recombinant Protein Production and its Removal Strategies: A Mini Review.
Zhao Y; Li H; Fan Z; Wang T
Curr Pharm Biotechnol; 2024; 25(6):665-675. PubMed ID: 37594091
[TBL] [Abstract][Full Text] [Related]
7. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing.
Valente KN; Lenhoff AM; Lee KH
Biotechnol Bioeng; 2015 Jun; 112(6):1232-42. PubMed ID: 25502542
[TBL] [Abstract][Full Text] [Related]
8. Discovery and characterization of CHO host cell protease-induced fragmentation of a recombinant monoclonal antibody during production process development.
Yang B; Li W; Zhao H; Wang A; Lei Y; Xie Q; Xiong S
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():1-10. PubMed ID: 30836312
[TBL] [Abstract][Full Text] [Related]
9. Protein A affinity chromatography of Chinese hamster ovary (CHO) cell culture broths containing biopharmaceutical monoclonal antibody (mAb): Experiments and mechanistic transport, binding and equilibrium modeling.
Grom M; Kozorog M; Caserman S; Pohar A; Likozar B
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1083():44-56. PubMed ID: 29522957
[TBL] [Abstract][Full Text] [Related]
10. Host cell protein impurities in chromatographic polishing steps for monoclonal antibody purification.
Levy NE; Valente KN; Lee KH; Lenhoff AM
Biotechnol Bioeng; 2016 Jun; 113(6):1260-72. PubMed ID: 26550778
[TBL] [Abstract][Full Text] [Related]
11. Purification of antibodies by precipitating impurities using Polyethylene Glycol to enable a two chromatography step process.
Giese G; Myrold A; Gorrell J; Persson J
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 938():14-21. PubMed ID: 24036248
[TBL] [Abstract][Full Text] [Related]
12. Process performance and product quality in an integrated continuous antibody production process.
Karst DJ; Steinebach F; Soos M; Morbidelli M
Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
[TBL] [Abstract][Full Text] [Related]
13. Mid-infrared spectroscopy-based antibody aggregate quantification in cell culture fluids.
Capito F; Skudas R; Kolmar H; Hunzinger C
Biotechnol J; 2013 Aug; 8(8):912-7. PubMed ID: 23712876
[TBL] [Abstract][Full Text] [Related]
14. Exploring the linkage between cell culture process parameters and downstream processing utilizing a plackett-burman design for a model monoclonal antibody.
Agarabi CD; Chavez BK; Lute SC; Read EK; Rogstad S; Awotwe-Otoo D; Brown MR; Boyne MT; Brorson KA
Biotechnol Prog; 2017 Jan; 33(1):163-170. PubMed ID: 27813291
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of host cell protein product-associated impurities in monoclonal antibody bioprocessing.
Levy NE; Valente KN; Choe LH; Lee KH; Lenhoff AM
Biotechnol Bioeng; 2014 May; 111(5):904-12. PubMed ID: 24254318
[TBL] [Abstract][Full Text] [Related]
16. The future of host cell protein (HCP) identification during process development and manufacturing linked to a risk-based management for their control.
Bracewell DG; Francis R; Smales CM
Biotechnol Bioeng; 2015 Sep; 112(9):1727-37. PubMed ID: 25998019
[TBL] [Abstract][Full Text] [Related]
17. Host cell protein dynamics in recombinant CHO cells: impacts from harvest to purification and beyond.
Hogwood CE; Bracewell DG; Smales CM
Bioengineered; 2013; 4(5):288-91. PubMed ID: 23328085
[TBL] [Abstract][Full Text] [Related]
18. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
[TBL] [Abstract][Full Text] [Related]
19. Purification of monoclonal antibodies entirely in flow-through mode.
Yamada T; Yamamoto K; Ishihara T; Ohta S
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():110-116. PubMed ID: 28728084
[TBL] [Abstract][Full Text] [Related]
20. A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation.
Könitzer JD; Müller MM; Leparc G; Pauers M; Bechmann J; Schulz P; Schaub J; Enenkel B; Hildebrandt T; Hampel M; Tolstrup AB
Biotechnol J; 2015 Sep; 10(9):1412-23. PubMed ID: 26212696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
